Complete Genomics' Stock Rebounds as Genomics Firms See Mixed February

Mar 02, 2012

NEW YORK (GenomeWeb News) – Shares of Complete Genomics rose 26 percent in February driven by an announcement that it had been selected by the Mayo Clinic's Center for Individualized Medicine to provide outsourced whole genome sequencing.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.